FHTX

Foghorn Therapeutics Inc.$4.12-0.24 (-5.50%)

Prev Close$4.36·MCap$297.7M·P/E—·Vol310.2K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$0.00

●

Active Insiders

last 12 mo

FHTX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 24, 2024	Costa Carlos	Chief People Officer	Sell	36,613	$10.04	$367.7K	0Exit
Sep 20, 2024	Costa Carlos	Chief People Officer	Sell	11,574	$10.05	$116.3K	0Exit
Sep 18, 2024	Costa Carlos	Chief People Officer	Sell	10,672	$10.04	$107.1K	0Exit
Sep 11, 2024	Bellon Steven F.	Chief Scientific Officer	Sell	20,000	$9.50	$190.0K	101,957
May 24, 2024	Flagship Pioneering Inc.		Buy	3,629,829	$5.51	$20.00M6.2% OS	1,814,915
Mar 12, 2024	Cavalie Fanny	Chief Strategy/Bus Ops Officer	Sell	11,000	$6.56	$72.1K	75,992
Aug 18, 2023	Agresta Samuel	Chief Medical Officer	Sell	311,297	$8.25	$2.57M0.5% OS	0Exit

The following table shows recent insider purchases of Foghorn Therapeutics Inc. (FHTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 24, 2024	Flagship Pioneering Inc.		Buy	3,629,829	$5.51	$20.00M6.2% OS	1,814,915

The following table shows recent insider sales of Foghorn Therapeutics Inc. (FHTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 24, 2024	Costa Carlos	Chief People Officer	Sell	36,613	$10.04	$367.7K	0Exit
Sep 20, 2024	Costa Carlos	Chief People Officer	Sell	11,574	$10.05	$116.3K	0Exit
Sep 18, 2024	Costa Carlos	Chief People Officer	Sell	10,672	$10.04	$107.1K	0Exit
Sep 11, 2024	Bellon Steven F.	Chief Scientific Officer	Sell	20,000	$9.50	$190.0K	101,957
Mar 12, 2024	Cavalie Fanny	Chief Strategy/Bus Ops Officer	Sell	11,000	$6.56	$72.1K	75,992
Aug 18, 2023	Agresta Samuel	Chief Medical Officer	Sell	311,297	$8.25	$2.57M0.5% OS	0Exit